AlSaleh Nuha, AlRammah Tamrah, Alatabani Alaa, Alsalem Abdulaziz, Alsheikh Tamara, AlRabah Razan, Al-Qattan Noha, Alhomod Abdulaziz, Alkhaldi Turki
Department of Surgery, College of Medicine, King Saud University Medical City (KSUMC), Riyadh, Saudi Arabia.
Department of Surgery, Diriayah Hospital, Riyadh Third Health Cluster Ministry of Health, Riyadh, Saudi Arabia.
Gland Surg. 2024 Jun 30;13(6):844-851. doi: 10.21037/gs-23-374. Epub 2024 Jun 27.
Mammographic breast density (MBD), a well-established factor linked to breast cancer, is the focus of this preliminary report among women across multiple centers in Riyadh. The study aims to identify risk factors associated with high breast density.
MBD was assessed at three hospitals in Riyadh, Saudi Arabia, using the American College of Radiology (ACR) categories: A (almost entirely fatty), B (scattered areas of fibroglandular density), C (heterogeneously dense), and D (extremely dense). Breast density distributions were analyzed in relation to age, body mass index (BMI), family history, parity, and hormonal therapy usage.
The study included 1,530 women, revealing an inverse association between dense breast proportion and age/BMI. Notably, 43.3% [95% confidence interval (CI): 43.2% to 43.5%] of women aged 40-79 years exhibited heterogeneously or highly dense breasts, with this proportion inversely correlated with age and BMI.
Healthcare providers should consider breast density for appropriate screening and, if necessary, recommend supplemental methods. Policymakers and healthcare providers, when discussing breast density notification legislation, should be mindful of its high prevalence, ensuring women notified have opportunities to evaluate breast cancer risk and pursue supplemental screening options if deemed appropriate.
乳腺钼靶密度(MBD)是一个与乳腺癌相关的既定因素,是利雅得多个中心女性群体初步报告的重点。该研究旨在确定与高乳腺密度相关的风险因素。
在沙特阿拉伯利雅得的三家医院使用美国放射学会(ACR)分类评估乳腺钼靶密度:A(几乎全为脂肪)、B(散在的纤维腺体密度区域)、C(不均匀致密)和D(极度致密)。分析乳腺密度分布与年龄、体重指数(BMI)、家族史、生育情况和激素治疗使用情况的关系。
该研究纳入了1530名女性,显示致密乳腺比例与年龄/体重指数呈负相关。值得注意的是,40 - 79岁女性中有43.3%[95%置信区间(CI):43.2%至43.5%]表现为不均匀或高度致密乳腺,这一比例与年龄和体重指数呈负相关。
医疗保健提供者应考虑乳腺密度以进行适当筛查,如有必要,推荐补充检查方法。政策制定者和医疗保健提供者在讨论乳腺密度告知立法时,应注意其高患病率,确保被告知的女性有机会评估乳腺癌风险,并在认为适当时寻求补充筛查选项。